Experts sound alarm over crisis that could threaten water supplies for millions: 'Abnormally low'
The Western United States is facing a critical environmental challenge: a persistent snow drought leading to alarming declines in water levels at major reservoirs like Lake Mead and Lake Powell, Discover Magazine reported.
Experts warn that if this trend continues, it could threaten water supplies for millions, affect agriculture, and increase wildfire risks.
Lake Mead and Lake Powell, two of the largest reservoirs in the U.S., could be in for another year of record-low water levels, as reported by Discover. This is primarily due to the ongoing snow drought happening throughout the Western U.S.
According to the U.S. Department of Agriculture, snow droughts "are periods of abnormally low snowpack for a time of year in a particular location."
One study, published in 2025, found that human-induced climate change has significantly altered snowpack dynamics, affecting regional water sources and ecosystems.
Snowpack contributes significantly to the functioning of many ecosystems. When accumulated snowpack melts, it creates meltwater, which goes into rivers and lakes that provide water for agriculture, fisheries, and communities. Without enough snowpack, research shows that water shortages could intensify.
"The human and ecosystem consequences of snow loss can extend far beyond the winter," Justin Mankin, associate professor of geography at Dartmouth University, shared with Agence France-Presse.
The National Integrated Drought Information System reported that much of the Western U.S. experienced extremely dry conditions. Because of these conditions, Southwest states like Arizona, Nevada, and Colorado are experiencing "exceptional snow drought."
Extreme weather events have always existed. However, human-caused climate change is making them more frequent and severe.
In response, policymakers, scientists, and communities are implementing various strategies to combat the impacts of our changing climate. Communities across the country are prioritizing water conservation policies, water restrictions, and infrastructure investments to improve water supplies and storage.
Do you take steps to conserve water at home?
All the time
Usually
Sometimes
Never
Click your choice to see results and speak your mind.
On an individual level, people can help protect water resources by adopting sustainable practices, such as reducing outdoor water use and supporting local conservation efforts. Simple actions like fixing leaks, turning the tap off when not in use, and using rain barrels can also have a big impact.
This guide on reducing water waste in your home can help you save money and water at the same time.
Join our free newsletter for good news and useful tips, and don't miss this cool list of easy ways to help yourself while helping the planet.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
a day ago
- Yahoo
Regeneron and Sanofi's dupilumab shows promise in AD trial
Regeneron Pharmaceuticals and Sanofi have announced promising outcomes from the open-label Phase IV DISCOVER trial of Dupixent(dupilumab) in treating moderate-to-severe atopic dermatitis (AD) in adolescents and adults with skin of colour. The data were presented at the 2025 Revolutionizing Atopic Dermatitis Conference. In the study, 120 subjects with AD and skin of colour received Dupixent biweekly. At the 24-week mark, 76% of them achieved a ≥75% improvement in overall disease severity, with some noticing benefits as early as two weeks. Additionally, 53% of patients saw a reduction in itch, and there was a 53% decrease in post-inflammatory hyperpigmentation from baseline. The trial's safety outcomes aligned with Dupixent's established safety profile in dermatological uses. Subjects in the DISCOVER trial, aged 12 years and above, were treated with Dupixent monotherapy based on weight. The primary endpoint was achieving a minimum of a 75% improvement on the Eczema Area and Severity Index (EASI-75) at 24 weeks. Secondary and additional endpoints are the proportion of subjects achieving ≥4-point improvement on the Peak-Pruritus Numerical Rating Scale (PP-NRS). The skin of colour was defined as per Fitzpatrick skin types IV-VI. AD, a chronic skin condition characterised by type 2 inflammation, can be particularly severe in individuals with skin of colour, often leading to more pronounced symptoms and skin lesions. Invented using Regeneron's VelocImmune technology, Dupixent is a monoclonal antibody that blocks the signalling of interleukin-4 and interleukin-13 pathways without being an immunosuppressant. It is a collaborative effort between Sanofi and Regeneron. The companies recently reported that the Phase III AERIFY-1 trial of itepekimab in former smokers who have inadequately controlled chronic obstructive pulmonary disease (COPD), met the primary goal. "Regeneron and Sanofi's dupilumab shows promise in AD trial" was originally created and published by Clinical Trials Arena, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Sign in to access your portfolio
Yahoo
3 days ago
- Yahoo
California scientists sound alarm on role of pesticides in raising resistance to antifungal drugs
The proliferation of new fungicides in the U.S. agricultural sector may be raising resistance to critical antifungal medications in humans and animals, infectious disease experts are warning. Although antifungal pesticides have become vital to combatting the spread of crop disease, the ongoing development of new such fungicides may be leaving people more vulnerable to severe infections, according to new commentary published in the New England Journal of Medicine. 'Antimicrobial resistant pathogens are a constant reminder for us to use agents judiciously,' lead author George Thompson, a professor of medicine at the University of California, Davis, said in a statement. 'We have learned that the widespread use of antibiotics for livestock resulted in the rapid development of resistance to antibacterials,' Thompson continued. 'We have similar concerns regarding the use of antifungals in the environment.' In the past few decades, fungi that cause severe infections in humans — such as the difficult-to-treat Candida auris — have undergone a rapid increase, the scientists noted. Yet because there are relatively few antifungals available to eradicate such microbes from the body, Thompson stressed that 'preventing resistance is of paramount importance.' In the U.S. today, the researchers found that there are about 75,000 hospitalizations and 9 million outpatient visits linked to fungal diseases every year, with direct annual costs amount to $6.7 billion to $7.5 billion. At the same time, the U.S. Department of Agriculture estimates that fungi cause between 10 percent to 20 percent of crop loss, at a cost of $100 billion to $200 billion annually, according to the report. However, scientists have now become increasingly aware that antifungal pesticides and antifungal drugs share some of the same mechanisms. The authors therefore warned that the promulgation of these chemicals 'may select for resistant fungi in the environment, which can then endanger human health.' The development of antifungal medications, meanwhile, is a difficult task due to the metabolic similarities shared by human and fungal cells, as well as the surge in antifungal resistance, the authors explained. Tackling this problem, they contended, requires what's known as a 'One Health' approach — a state that recognizes how human, animal and environmental health are all related. As scientists research future solutions, having representatives from each of these sectors in the room will be increasingly critical, the commentary argued. Shared decision-making among national and global regulators, the researchers added, would both be cost-effective and would help avoid the 'riskier prospects of the rapid spread of resistant pathogens.' Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
The Hill
3 days ago
- The Hill
California scientists sound alarm on role of pesticides in raising resistance to antifungal drugs
The proliferation of new fungicides in the U.S. agricultural sector may be raising resistance to critical antifungal medications in humans and animals, infectious disease experts are warning. Although antifungal pesticides have become vital to combatting the spread of crop disease, the ongoing development of new such fungicides may be leaving people more vulnerable to severe infections, according to new commentary published in the New England Journal of Medicine. 'Antimicrobial resistant pathogens are a constant reminder for us to use agents judiciously,' lead author George Thompson, a professor of medicine at the University of California, Davis, said in a statement. 'We have learned that the widespread use of antibiotics for livestock resulted in the rapid development of resistance to antibacterials,' Thompson continued. 'We have similar concerns regarding the use of antifungals in the environment.' In the past few decades, fungi that cause severe infections in humans — such as the difficult-to-treat Candida auris — have undergone a rapid increase, the scientists noted. Yet because there are relatively few antifungals available to eradicate such microbes from the body, Thompson stressed that 'preventing resistance is of paramount importance.' In the U.S. today, the researchers found that there are about 75,000 hospitalizations and 9 million outpatient visits linked to fungal diseases every year, with direct annual costs amount to $6.7 billion to $7.5 billion. At the same time, the U.S. Department of Agriculture estimates that fungi cause between 10 percent to 20 percent of crop loss, at a cost of $100 billion to $200 billion annually, according to the report. However, scientists have now become increasingly aware that antifungal pesticides and antifungal drugs share some of the same mechanisms. The authors therefore warned that the promulgation of these chemicals 'may select for resistant fungi in the environment, which can then endanger human health.' The development of antifungal medications, meanwhile, is a difficult task due to the metabolic similarities shared by human and fungal cells, as well as the surge in antifungal resistance, the authors explained. Tackling this problem, they contended, requires what's known as a 'One Health' approach — a state that recognizes how human, animal and environmental health are all related. As scientists research future solutions, having representatives from each of these sectors in the room will be increasingly critical, the commentary argued. Shared decision-making among national and global regulators, the researchers added, would both be cost-effective and would help avoid the 'riskier prospects of the rapid spread of resistant pathogens.'
